FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2408718111> ?p ?o ?g. }

• W2408718111 endingPage "2495" @default.
• W2408718111 startingPage "2487" @default.
• W2408718111 abstract "BACKGROUND Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are commonly used antihypertensive medications that have been reported to affect aberrant angiogenesis and the dysregulated inflammatory response. Because of such mechanisms, it was hypothesized that these medications might affect the tumor response to neoadjuvant radiation in patients with rectal cancer. METHODS One hundred fifteen patients who were treated with neoadjuvant radiation at the University of Wisconsin (UW) between 1999 and 2012 were identified. Univariate analyses were performed with anonymized patient data. In a second independent data set, 186 patients with rectal cancer who were treated with neoadjuvant radiation at the Queen's Medical Center of the University of Hawaii (UH) between 1995 and 2010 were identified. These data were independently analyzed as before. Multivariate analyses were performed with aggregate data. RESULTS Among patients taking ACEIs/ARBs in the UW data set, a significant 3-fold increase in the rate of pathologic complete response (pCR) to neoadjuvant therapy (52% vs 17%, P = .001) was observed. This finding was confirmed in the UH data set, in which a significant 2-fold–increased pCR rate (24% vs 12%, P = .03) was observed. Identified patient and treatment characteristics were otherwise balanced between patients taking and not taking ACEIs/ARBs. No significant effect was observed on pCR rates with other medications, including statins, metformin, and aspirin. Multivariate analyses of aggregate data identified ACEI/ARB use as a strong predictor of pCR (odds ratio, 4.02; 95% confidence interval, 2.06-7.82; P < .001). CONCLUSIONS The incidental use of ACEIs/ARBs among patients with rectal cancer is associated with a significantly increased rate of pCR after neoadjuvant treatment. Cancer 2016;122:2487–95. © 2016 American Cancer Society." @default.
• W2408718111 created "2016-06-24" @default.
• W2408718111 creator A5000298044 @default.
• W2408718111 creator A5014133933 @default.
• W2408718111 creator A5023121753 @default.
• W2408718111 creator A5027688104 @default.
• W2408718111 creator A5030470462 @default.
• W2408718111 creator A5033803080 @default.
• W2408718111 creator A5036130260 @default.
• W2408718111 creator A5042432574 @default.
• W2408718111 creator A5048206716 @default.
• W2408718111 creator A5053380580 @default.
• W2408718111 creator A5053434770 @default.
• W2408718111 creator A5060115400 @default.
• W2408718111 creator A5083576766 @default.
• W2408718111 date "2016-05-20" @default.
• W2408718111 modified "2023-10-03" @default.
• W2408718111 title "Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers" @default.
• W2408718111 cites W108690756 @default.
• W2408718111 cites W155262293 @default.
• W2408718111 cites W1909153829 @default.
• W2408718111 cites W1988071481 @default.
• W2408718111 cites W1992112921 @default.
• W2408718111 cites W1992146834 @default.
• W2408718111 cites W2001442212 @default.
• W2408718111 cites W2003102575 @default.
• W2408718111 cites W2017233105 @default.
• W2408718111 cites W2027827385 @default.
• W2408718111 cites W2034099804 @default.
• W2408718111 cites W2040660199 @default.
• W2408718111 cites W2060287969 @default.
• W2408718111 cites W2062592416 @default.
• W2408718111 cites W2063872981 @default.
• W2408718111 cites W2064951158 @default.
• W2408718111 cites W2069825238 @default.
• W2408718111 cites W2077999719 @default.
• W2408718111 cites W2082573645 @default.
• W2408718111 cites W2083352053 @default.
• W2408718111 cites W2095273472 @default.
• W2408718111 cites W2103552199 @default.
• W2408718111 cites W2103571483 @default.
• W2408718111 cites W2105473163 @default.
• W2408718111 cites W2107383477 @default.
• W2408718111 cites W2113419020 @default.
• W2408718111 cites W2114927900 @default.
• W2408718111 cites W2119459301 @default.
• W2408718111 cites W2126949664 @default.
• W2408718111 cites W2140828776 @default.
• W2408718111 cites W2143655828 @default.
• W2408718111 cites W2155444107 @default.
• W2408718111 cites W2156269898 @default.
• W2408718111 cites W2165345246 @default.
• W2408718111 cites W2170715646 @default.
• W2408718111 cites W868278633 @default.
• W2408718111 doi "https://doi.org/10.1002/cncr.30079" @default.
• W2408718111 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4998053" @default.
• W2408718111 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27203227" @default.
• W2408718111 hasPublicationYear "2016" @default.
• W2408718111 type Work @default.
• W2408718111 sameAs 2408718111 @default.
• W2408718111 citedByCount "37" @default.
• W2408718111 countsByYear W24087181112017 @default.
• W2408718111 countsByYear W24087181112018 @default.
• W2408718111 countsByYear W24087181112019 @default.
• W2408718111 countsByYear W24087181112020 @default.
• W2408718111 countsByYear W24087181112021 @default.
• W2408718111 countsByYear W24087181112022 @default.
• W2408718111 countsByYear W24087181112023 @default.
• W2408718111 crossrefType "journal-article" @default.
• W2408718111 hasAuthorship W2408718111A5000298044 @default.
• W2408718111 hasAuthorship W2408718111A5014133933 @default.
• W2408718111 hasAuthorship W2408718111A5023121753 @default.
• W2408718111 hasAuthorship W2408718111A5027688104 @default.
• W2408718111 hasAuthorship W2408718111A5030470462 @default.
• W2408718111 hasAuthorship W2408718111A5033803080 @default.
• W2408718111 hasAuthorship W2408718111A5036130260 @default.
• W2408718111 hasAuthorship W2408718111A5042432574 @default.
• W2408718111 hasAuthorship W2408718111A5048206716 @default.
• W2408718111 hasAuthorship W2408718111A5053380580 @default.
• W2408718111 hasAuthorship W2408718111A5053434770 @default.
• W2408718111 hasAuthorship W2408718111A5060115400 @default.
• W2408718111 hasAuthorship W2408718111A5083576766 @default.
• W2408718111 hasBestOaLocation W24087181112 @default.
• W2408718111 hasConcept C121608353 @default.
• W2408718111 hasConcept C126322002 @default.
• W2408718111 hasConcept C126894567 @default.
• W2408718111 hasConcept C143998085 @default.
• W2408718111 hasConcept C156957248 @default.
• W2408718111 hasConcept C170493617 @default.
• W2408718111 hasConcept C27016395 @default.
• W2408718111 hasConcept C2776694085 @default.
• W2408718111 hasConcept C2777628954 @default.
• W2408718111 hasConcept C2777802072 @default.
• W2408718111 hasConcept C2778292576 @default.
• W2408718111 hasConcept C2908929049 @default.
• W2408718111 hasConcept C44249647 @default.
• W2408718111 hasConcept C509974204 @default.
• W2408718111 hasConcept C526805850 @default.

• next